SULJE VALIKKO

avaa valikko

Owen A. O'Connor | Akateeminen Kirjakauppa

Haullasi löytyi yhteensä 4 tuotetta
Haluatko tarkentaa hakukriteerejä?



Novel Targeted Drugs for the Treatment of Lymphoma: The Biological Basis for Innovative Drug Discovery and Development
Owen A. O'Connor; Jennifer E. Amengual; John Gerecitano
Humana (2028)
Kovakantinen kirja
110,10
Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
The Peripheral T-Cell Lymphomas
Owen A. O'Connor; Won Seog Kim; Pier L. Zinzani
John Wiley and Sons Ltd (2021)
Kovakantinen kirja
181,70
Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
Precision Cancer Therapies, Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies - From Concept to Practi
Owen A. O'Connor; Stephen M. Ansell; John F. Seymour
John Wiley and Sons Ltd (2023)
Kovakantinen kirja
165,40
Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
Precision Cancer Therapies, Immunologic Approaches for the Treatment of Lymphoid Malignancies - From Concept to Practice
Owen A. O'Connor; Stephen M. Ansell; John G. Gribben
John Wiley and Sons Ltd (2024)
Kovakantinen kirja
165,40
Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
Novel Targeted Drugs for the Treatment of Lymphoma: The Biological Basis for Innovative Drug Discovery and Development
110,10 €
Humana
Sivumäärä: 400 sivua
Asu: Kovakantinen kirja
Painos: 1st ed. 2028
Julkaisuvuosi: 2028, 11.06.2028 (lisätietoa)
Kieli: Englanti

Over the past decade, there has been an explosion in the number of new drugs being developed for the treatment of cancer. This has become particularly true in the case of lymphoma. However, what frequently remains unclear to many is that this increase in new agents, and the often novel targets they affect, is a direct product of our never ending quest to understand the fundamentals of cancer cell biology. Targeting these unique pathogenetic mechanisms is the most attractive strategy for altering the natural history of any malignancy, and the pace at which we are clarifying this biology is truly daunting.

One of the primary goals of Novel Targeted Drugs for the Treatment of Lymphoma is to emphasize this new biology, allowing it it become the cornerstone for understanding how and why these novel agents are moving rapidly into the mainstream of patient care. Each section starts with a comprehensive chapter on the important aspects of the relevant biology, written by an authority in that field. Subsequent chapters focus on discrete agents, and how they establish the 'proof of principle'. Every effort is made to present a fair and unbiased account of those agents, with particular attention being paid to those compounds that appear the most differentiated. Well organized and easy to read, this book is a valuable resource for all practitioners in the field.



Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
LISÄÄ OSTOSKORIIN
Tuote on tilapäisesti loppunut ja sen saatavuus on epävarma. Seuraa saatavuutta.
Myymäläsaatavuus
Helsinki
Tapiola
Turku
Tampere
Novel Targeted Drugs for the Treatment of Lymphoma: The Biological Basis for Innovative Drug Discovery and Development
Näytä kaikki tuotetiedot
ISBN:
9781588299321
Sisäänkirjautuminen
Kirjaudu sisään
Rekisteröityminen
Oma tili
Omat tiedot
Omat tilaukset
Omat laskut
Lisätietoja
Asiakaspalvelu
Tietoa verkkokaupasta
Toimitusehdot
Tietosuojaseloste